Randy Vogenberg, PhD

Randy Vogenberg, PhD

Institute for Integrated Healthcare (IIH), and Employer-Provider Interface Council (EPIC) of the Hospital Quality Foundation at Employer-Provider Interface Council (EPIC), Hospital Quality Foundation

Joined 07/15/2016


Dr. Randy Vogenberg, Principal, Institute for Integrated Healthcare; Co-Leader, National Employer Initiative on Specialty Pharmacy; & was a Co-Founder, National Institute of Collaborative Healthcare (NICH); is a health care expert on health-system delivery & economics, and health related solution innovation research. Most recently he partnered with HQF in developing "EPIC". His broad hospital and managed care expertise includes current or future trends around financing, market excellence, and benefit management or design - including Co-Project Leader for the National Employer Biologics & Specialty Pharmacy Initiative through the Midwest Business Group on Health. See leader & highly requested speaker on applied health systems research, he authored programs or books on self-funded health benefits, managed markets, hospitals, & integrated medical-pharmacy benefit management. An entrepreneur, he co-founded firms that provide a relational view of key market stakeholders, such as ACCESS MARKET INTELLIGENCE (AMI) that also provides insights into benefit advisors, employers, health systems, specialty pharmacy, and health plans/PBMs. Through NICH, he drives disruption for health innovation, incubation and implementation. academic relationships include Rutgers HOPE Center, and former Senior Fellow at the Jefferson School of Population Health. Currently is an Adjunct Professor at the University of Rhode Island CoP & Rutgers University CoP as well as the Univ.of Illinois CoP. Specialties: Managed Markets, Employers & benefit advisors; hospitals, health-systems; B-to-B coalitions; Health benefit coverage, medical and pharmacy benefits, insurance, finance; hospital economics and finance; health care and pharmaceutical economics; health policy; manufacturers of pharmaceuticals, biologics, diagnostics, devices, and medical equipment; education and strategic business perspectives on U.S. health care.
Rewards expand_more






Level: LEVEL 04 (12mo pts: 2035 pts)

Rating: 4.64/5 stars (684 ratings)

Lifetime points: 3580 pts

Experience expand_more
Fellow of the Foundation at Foundation for Health Smart Consumers
President 2017-2018, Co-President 2018-2019 & Member, Board of Directors at North Greenville Rotary Club, Rotary International
Co Founder at National Institute for Collaborative Healthcare, LLC (NICH)
Co-Founder at Access Market Intelligence, LLC (AMI)
Principal at Institute for Integrated Healthcare (IIH)
Chief Health Economics Officer at Hospital Quality Foundation, LLC and Transition Patient Services, LLC
Principal at Institute for Integrated Healthcare (IIH)
Fellow, ASHP at ASHP member & Fellow
National Employer Initiative on Biologic & Specialty Drugs at Midwest Business Group on Health
Collaboration Leader at National Institute of Collaborative Healthcare (NICH), LLC
Fellow & Board Chairperson at Employer-Provider Interface Council (EPIC), Hospital Quality Foundation
Follow back expand_more

Followed by 0

No followers yet.

Activities expand_more


View More
group 0Follower(s)
Start a Talk
Health - Sensing Trends and Disruptions Impacting the Health Workforce
We're assembling an online advisory panel to explore the workforce disruptions impacting the healthcare, life sciences, and wellness industries. Specifically, we'll discuss the technological, social, economic, demographic, environmental, and geopolitical shifts that are shaping the landscape of the healthcare and life sciences workforce and envision what the future holds for the industry.

In this exclusive online panel of 15-20 experts, you'll have the opportunity to learn collaboratively and advance innovation in this field. All engagement is online and at your convenience.
Next-Generation Oncology Treatments
Understanding the potential for new cancer drug treatments from Oncologists
The Evolution of the HR Function: COVID-19 Challenges and Opportunities
HR Challenges & Opportunities Resulting From Covid-19 - What You HR Leaders & Decision Makers Experiencing & What Will Their Priorities Be Going Forward
The Future of Employee Benefits for Small Business
small business insurance benefits
Next-Generation Oncology Treatments
Understanding of potential for new cancer drug from Oncologists
The Future of Employee Benefits
Looking to explore a futurist's view of the Future of Employee Benefits

What types of health activation benefits would be offered in 5-10 years by the most differentiated health plan in the future? Example: health & wellness products, financial well-being, precision medicine, onsite health clinics, virtual care

How do health plans take full advantage of exponential technologies and new business models to structure incentive programs and behavior change programs?

How does employment and employment driven insurance change 5 / 10 years from now?

Disruptions Impacting The Future of Health Plans
The future of health plans.

How will insurance companies look in 5-10 years? What technology will be disrupting and how will it be disrupting? What are use cases for this type of technology changing the way insurance companies go to market in the future?
The Future of Business Risk Management for Large Companies
Our client (a commercial insurance carrier) is looking to develop a strategy and set of actionable initiatives that will allow them to improve cross-selling across their lines of business. To achieve this objective, our client is looking to better understand opportunities to provide their customers with additional value and deepen / broaden their overall relationship.

Key Topics to Explore: Customer needs and preferences for interacting with a commercial insurance carrier; Moments that matter across the customer lifecycle; Opportunities to deepen relationships with a commercial insurance carrier; Perceived value from bundling products; Perception of strengths / weaknesses of different commercial insurance carriers
The Future of Health Insurance Plans in the US
We are seeking to vet & validate a set of hypotheses around health insurance plans in the US --- both with health insurance brokers (those who sell to employers) and the employers (Human Resource HR executives) of both small-mid and large size companies.

Day 1: Validate a ‘long list’ of health plan service components (i.e., review an existing taxonomy of features, experiences, or standards that the ‘customer service’ organization in a health plan should offer and provide input on what to add/drop/modify). Long list might be 50-100 items, possibly longer (we’ll get clearer on these questions of scale).

Day 2: Identify the subset of components that matter most for driving the choice of health plan provider (i.e., Do any matter more than the cost of the plan? Cost held equal, which are differentiators versus table stakes?). Assume fewer than 20 components make this cut.

Day 3: “Conjoint-light” analysis on that resulting subset (based on comparing pairs of features across all combinations, what are the ‘win rates’ for each feature)

Day 4: Qualitative input on the subset (provide more qualitative commentary on why certain features are important, what can be done to differentiate them, what ‘best’ looks/feels like in more detail, etc)
Exploring Best Practices in Accelerating Consumer Tests for OTC Drugs
Fastest way to go from receipt of new materials to placement of a OTC topical drug product in a consumer test in a safe, legal ethical way.
The Future of Personalized Healthcare Enabled by Digital Technologies
PPMD Sponsors: Jackie Biglin, Bill Fera
Team Members: Heather Nelson, Lindsay MacDonald, Eddie Wilson, Amy McDonough, Sam Hicks

By 2033, imagining personalized healthcare enabled by digital and innovative technologies... Delivering a customer-focused approach that will enable healthcare organizations to personalize medicine and improve patient outcomes.

Additional context below:
Imagine a world where the unique mapping of your own genome, behavior, social and environmental factors has allowed doctors to not only treat, but also prevent [and anticipate], the future diseases for which you are individually at greatest risk, all of which is directed and controlled from the simplicity of a single, personal device. By 2033, you will no longer need to imagine – personalized healthcare enabled by digital and innovative technologies will be the new reality. By using personalized DNA testing to understand the disease risk profile of every individual patient together with your personal habits, preferences and social environment, we can proactively keep populations healthy and target specific treatments for diseases based on their personal genetic makeup.
Understanding the Challenges of Workshop Facilitators in Qualitative Market Research
I want to build a persona of workshop facilitators for qualitative market research. I want to better understand their unmet needs, alternatives and what needs to be true about a solution that would address some of their toughest issues.
The Future of Personalized Medicine in Life Sciences & Healthcare
Life Sciences Topic #1: The Future of Personalized Medicine in Life Sciences & Healthcare

Topic Description: Impact of Personalized Medicine within the Life Sciences and Healthcare Industry

- Example Question: How can the ecosystem players reduce cost associated with the development and delivery of personalized medicine?

- Specifically around the supply chain function?

Add at least 3 tags
Your tags